Sign in
CompletedNo phase

Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease

Key facts

Who runs it
Tor Biering-Sørensen
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
308,978 people enrolled
Started
1 Oct 2024
Ended
31 May 2025
Type of study
Interventional, 7 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Behavioral Economic Principles
Record updated
12 September 2025

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Age 18-64 years
  • Must be registered in the Danish nationwide registries as meeting at least one of the following eligibility criteria for free-of-charge influenza vaccination in the Danish public health system:; Chronic lung disease; Chronic cardiovascular disease other than hypertension; Type 1 or type 2 diabetes mellitus; Congenital or acquired immunodeficiency; Impaired breathing due to muscular weakness; Chronic renal or hepatic insufficiency; Other chronic conditions with an increased risk of severe influenza as determined by the treating physician
  • Access to the official, mandatory Danish electronic mailbox system

Who cannot take part

  • None

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. Conducted during the 2023/2024 influenza season, the first NUDGE-FLU-CHRONIC trial demonstrated the effectiveness of behavioral nudging letters in increasing influenza vaccination rates among adults aged 18-64 years with chronic diseases in Denmark. This present study will once again investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among adults aged 18-64 years with chronic diseases including whether the effectiveness of the previously successful strategies can be confirmed during a subsequent influenza season.

The 7 groups in the trial

  • Usual CareNo study treatment, for comparison

    No letter

  • Standard LetterTreatment being tested

    This group will receive a standard letter on the benefits of influenza vaccination without behavioral economic enhancement

    Treatment: Behavioral Economic Principles

  • Repeated LetterTreatment being tested

    The standard letter sent out two times instead of once

    Treatment: Behavioral Economic Principles

  • Cardiovascular Gain-Framing LetterTreatment being tested

    Text added to the standard letter highlighting potential cardiovascular benefits of influenza vaccination

    Treatment: Behavioral Economic Principles

  • Repeated Cardiovascular Gain-Framing LetterTreatment being tested

    The cardiovascular gain-framing letter sent out two times instead of once

    Treatment: Behavioral Economic Principles

  • Respiratory Gain-Framing LetterTreatment being tested

    Text added to the standard letter highlighting potential respiratory disease-related benefits of influenza vaccination

    Treatment: Behavioral Economic Principles

  • Implementation Intention Prompt LetterTreatment being tested

    Implementation intention prompt added to the standard letter

    Treatment: Behavioral Economic Principles

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
12 September 2025